Literature DB >> 15924148

Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.

Federica Sabatini1, Loredana Petecchia, Manuela Tavian, Vanina Jodon de Villeroché, Giovanni A Rossi, Danièle Brouty-Boyé.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells able to differentiate along different pathways including chondrogenic, osteogenic and adipogenic lineages. MSCs with a fibroblast-like morphology have been identified in human fetal lung. However, their frequency and characterization in human adult lung have not been yet evaluated. Therefore, we analyzed the mesenchymal phenotype and differentiation ability of cultured human adult bronchial fibroblast-like cells (Br) in comparison with those of mesenchymal cell progenitors isolated from fetal lung (ICIG7) and adult bone marrow (BM212) tissues. Surface immunophenotyping by flow cytometry revealed a similar expression pattern of antigens characteristic of marrow-derived MSCs, including CD34 (-), CD45 (-), CD90/Thy-1 (+), CD73/SH3, SH4 (+), CD105/SH2 (+) and CD166/ALCAM (+) in Br, ICIG7 and BM212 cells. There was one exception, STRO-1 antigen, which was only weakly expressed in Br cells. Analysis of cytoskeleton and matrix composition by immunostaining showed that lung and marrow-derived cells homogeneously expressed vimentin and nestin proteins in intermediate filaments while they were all devoid of epithelial cytokeratins. Additionally, alpha-smooth muscle actin was also present in microfilaments of a low number of cells. All cell types predominantly produced collagen and fibronectin extracellular matrix as evidenced by staining with the monoclonal antibodies to collagen prolyl 4-hydroxylase and fibronectin isoforms containing the extradomain (ED)-A together with ED-B in ICIG7 cells. Br cells similarly to fetal lung and marrow fibroblasts were able to differentiate along the three adipogenic, osteogenic and chondrogenic mesenchymal pathways when cultured under appropriate inducible conditions. Altogether, these data indicate that MSCs are present in human adult lung. They may be actively involved in lung tissue repair under physiological and pathological circumstances.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924148     DOI: 10.1038/labinvest.3700300

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  83 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 2.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.

Authors:  Maria Mirotsou; Tilanthi M Jayawardena; Jeffrey Schmeckpeper; Massimiliano Gnecchi; Victor J Dzau
Journal:  J Mol Cell Cardiol       Date:  2010-08-19       Impact factor: 5.000

3.  Regulation of fibroblast lipid storage and myofibroblast phenotypes during alveolar septation in mice.

Authors:  Stephen E McGowan; Diann M McCoy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-22       Impact factor: 5.464

Review 4.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 5.  Mesenchymal stem cell preparations--comparing apples and oranges.

Authors:  Wolfgang Wagner; Anthony D Ho
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

7.  Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells.

Authors:  Feng Liu; Yasuto Akiyama; Sachiko Tai; Kouji Maruyama; Yoshihiro Kawaguchi; Kouji Muramatsu; Ken Yamaguchi
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 8.  Mesenchymal progenitor cell research: limitations and recommendations.

Authors:  Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

Review 9.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

10.  Do current bladder smooth muscle cell isolation procedures result in a homogeneous cell population? Implications for bladder tissue engineering.

Authors:  Arun K Sharma; Jena L Donovan; Jennifer A Hagerty; Ryan R Sullivan; Seby L Edassery; Daniel A Harrington; Earl Y Cheng
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.